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Objective: The immune compromised patients after treatment of oral cancer may have a chance of infection by drug-resistant opportunistic microbes. We investigated 
the occurrence of opportunistic microorganisms in aged individuals receiving follow-up 
examinations after treatment of oral cancer in China. Material and Methods: These patients 
were used as test group and the respective age grouped healthy individuals as control 
group. In this study, the oral cavity microorganisms such as bacteria and yeast were taken 
for the analysis. After the screening of representative microorganisms, their aptitude of 
pervasiveness against drugs was studied. Here, we used antimicrobial agents which are 
common in clinical practice. We also performed studies to investigate the presence of 
toxin genes in methicillin-resistant S. aureus (MRSA). Results: The results indicate that 
the prevalence of drug-resistant microbes was more pronounced in oral cancer patients 
after initial treatment above 70 years old. The oxacillin resistance of S. aureus isolate 
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compromise in elderly patients. Conclusions: This study reveals the occurrence of drug-
resistant opportunistic microorganisms in oral cavity after treatment for oral cancer in 
aged individuals. Special attention should be directed to MRSA during the treatment of 
oral cancer, and to realize the fact of immune compromise in elderly patients. 
Keywords: Oral cancer. Dental infection control. Drug resistance. Opportunistic infections. 
Prevention and control.
INTRODUCTION
The term oral cavity refers to lips, buccal 
mucosa, alveolar ridges, retro molar trigone, hard 
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of the tongue. Oral cancer or oral cavity cancer, a 
subtype of head and neck cancer, is any cancerous 
tissue growth located in the oral cavity24. The most 
common oral cancer is squamous cell carcinoma 
(SCC) that affects the tissue lining of the oral 
cavity5. Oral cancer is the eleventh most common 
cancer in the world with an estimated 267,000 
cases and 128,000 deaths in around 2000, two-
third of which occur in developing countries. The 
incidence of oral cancer is increasing in several 
parts of the world, particularly in Australia, Japan 
and parts of Europe. Oro-pharyngeal cancer is a 
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cancer occurrence is particularly high in males. 
Incidence rates for oral cancer vary in men from 
1 to 10 cases per 100,000 populations in many 
countries. Tobacco and alcohol are regarded as the 
major causes of oral cancer10.
The immune compromised patients after 
treatment of oral cancer may have a chance 
of infection by drug-resistant opportunistic 
microbes. Such microbes that originate in the oral 
cavity, representative microorganisms include 
Staphylococcus aureus, Pseudomonas aeruginosa, 
and Candida albicans1,14. Pseudomonas aeruginosa 
is increasingly recognized as an emerging 
opportunistic pathogen of clinical relevance. One of 
the most worrying characteristics of P. aeruginosa 
is its low antibiotic susceptibility23. This low 
susceptibility is attributable to a concerted action 
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S.No. Antibiotics Sensitivity 
dose
Resistance 
dose
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1 Oxacillin <0.25 >2
2 Arbekacin <4 >8
3 Vancomycin <2 >8
4 Teicoplanin <8 >16
5 Linezolid <2 >4
6 Fluconazole <8 >64
7 	
 <4 >32
8 Itraconazole <0.125 >1
9 Miconazole <0.5 >1
10 Amphotericin B <1 >2
11 Voriconazole <1 >4
12 Micafungin <1 >2
13 Imipenem/
cilastatin
<16 >16
14 Amikacin <32 >32
15  <4 >4
Figure 1- Antibiotics used to test the antimicrobial activity
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encoded antibiotic resistance genes15. Most of these 
organisms have become drug-resistant, which has 
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diseases. The Candida species educe the infectious 
disease candidiasis, which causes infections such as 
oral thrush and vaginitis as well as life-threatening 
diseases, known as candidemia16. C. albicans are 
yeast that normally inhabits the human mouth and 
skin, where it generally uneventfully coexists with 
a variety of other microorganisms. An infection 
occurs when the balance of bacteria in the body 
is disrupted, especially in immunocompromised 
situations, allowing drug-resistant Candida 
species to proliferate and overcome other healthy 
microorganisms11. Immunocompromised situations 
are frequently seen in older individuals, infants, 
people infected with HIV, and individuals with 
cancer; oral cancer can reduce immunity in the 
maxillofacial region1,14. The principal treatments for 
oral cancer are surgical excision, radiotherapy, and 
chemotherapy, employed alone or in combination13.
Currently, the systemic applications of 
antibacterial drugs have shown better results on 
curing diseases than local application, which could 
induce drug-resistant bacteria in the particular 
area2,3. In this study, we have investigated the 
reason behind the frequent cause of oral infection 
after the treatment of oral cancer in elderly 
Chinese.
MATERIAL AND METHODS
Patient study
Out of several elderly patients (60–95 years 
old), 128 patients who had undergone treatment 
for oral-cavity related problems participated in the 
study at Ninth People’s Hospital, Shanghai Jiao 
Tong University. We have excluded patients with 
other systemic diseases like autoimmune disease or 
diabetes to avoid misleading of our parameter. The 
participants were divided into two groups: Group 
I - the patients undergone oral cancer treatment 
(n=93; 41 men, 52 women; average age 68.1±8.3 
years) ranging from 1 month to 7 years after the 
initial treatment, 43 members were involved in 
species identification, remaining 50 members 
involved in drug-resistant test. These patients 
have been treated with surgery, chemo and/or 
radiotherapy; Group II - the control (n=35; 15 
men, 20 women; average age 70.2±10.1 years), 
who had received treatment for oral cavities or 
with no history of any cancer treatment. The 
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Hospital of Shanghai Jiao Tong University, according 
to Helsinki Declaration II, approved the study. 
Written informed consent was obtained from each 
participant.
Sample collection
Microbes were collected from the areas of 
surgery (Group I), tongue, gingiva, and palate by 
using sterilized dry cotton swabs. After wetting, the 
cotton swab was immediately put into an airtight 
sterilized test tube. To collect anaerobic microbes 
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deep area of the incision. Collected samples were 
immediately put into an anaerobic sample collection 
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was collected from each subject for the analysis.
Microbial cultivation
The microorganisms were cultured on nalidixic 
acid/cetrimide agar (Sigma-Aldrich Chemie GmbH, 
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species, while Mannital Salt agar (Acumedia 
Manufacturers, USA) was used for the first 
screening of Staphylococcus species and Brilliance 
Candida		FK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The nalidixic acid/cetrimide agar and Mannital Salt 
agar plates were incubated at 37°C under aerobic 
conditions for 2 days, while Candida-GS agar plates 
were incubated at 30°C for 3 days.
Microbial species detection and antimicrobial 
testing
The morphological assessment was carried 
out from the colonies on the plates, and those 
with different shapes were collected, gram 
stained and observed under a light microscope 
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two species in same isolates were presented in two sets of group I & II in each species
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for species detection. Genomic DNA from each 
colony was obtained using a Wizard genomic 
extraction kit (Promega, Madison, WI, USA). For 
Staphylococcus species, cells were treated with 1 
mg/mL of lysostaphin in Tris-EDTA buffer (TE; 10 
mM Tris-Cl, 1 mM EDTA, pH 8.0) at 37°C for 1 h 
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with bacterial universal primers for 16S rDNA and 
26S rDNA for fungus, followed by DNA sequencing. 
DNA sequencing was performed using an ABI Prism 
3100 Genetic Analyzer (Applied Biosystems, Tokyo, 
Japan) with a Big Dye Cycle Sequencing reaction 
kit (AB Applied Biosystems). Identification of 
experimentally determined nucleotide sequences 
using sequence databases was performed by 
Basic Local Alignment Search Tool (BLAST). The 
antimicrobial activity was tested with respective 
antibiotics used commonly in clinical practice 
(Figure 1).
Statistical analysis
Statistical analyses were conducted using SPSS 
15.0 (SPSS Inc., U.S.A.) and any differences at 
p<0.05 level were considered as statistically 

	K			
	
	
were compared using independent student t-test.
RESULTS
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The samples were collected from surgical scar, 
saliva, gingiva, and palate of 78 elderly Chinese 
(43 cases of group I and 35 cases of group II). 
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Candida, Staphylococcus and Pseudomonas 
species. The graphical representation for the 
percentage of species identification from one 
species in one isolates or two species in same 
isolates were presented in two sets of group I & 
II in each species (Figure 2). Statistical analysis 
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in the number of isolated microorganisms or the 
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Candida Species 
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Group I (n=43) Group II (n=35)
No. of positive 
samples
Percentage (%) No. of positive 
samples
Percentage (%)
C. albicans 24 55.8 10 28.6*
C. glabrata 21 48.8 8 22.8*
C. krusei 12 27.9 6 17.1
C. guilliermondii 4 9.3 1 2.8
C. africana 5 11.6 2 5.7
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number of participants with these isolates.
Candida species
The universal primers for fungi, 26S rDNA 
sequencing was used to identify the Candida 
species (Figure 3). The Candida species isolated 
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C. albicans (43.6%), C. glabrata (37.2%), C. krusei 
(23.1%), C. africana (9%) and C. guilliermondii 
(6.4%). The number of Candida species isolated 
from group I were greater than that of group II. 
On comparison between the groups, the C. albicans 
were found to be the dominant species in both 
group I (55.8%) and group II (28.6%). However, 
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between groups. Similarly, C. glabrata were found 
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difference between group I (48.8%) and group 
II (22.8%) participants (Table 1). However, no 
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and C. guilliermondii species, rather very less 
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groups (Table 1).
Bacterial species
The universal primers for bacteria, 16S rDNA 
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(Figure 4). The bacterial species isolated from 
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Staphylococcus (59%), Pseudomonas (53.8%), 
Streptococcus (44%), Neisseria (37.2%), 
Actinomyces (29.5%) and Veillonella (25.6), which 
are mostly found in the surgical scar and saliva. 
On comparison between two groups of isolates, the 
Streptococcus, Staphylococcus, Pseudomonas and 
Neisseria		
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	F`{{|@	
in percentage of these species between groups 
I and II (Table 2). In Group I, the numbers of 
positive isolates of bacterial species were greater 
than that of the control group using traditional oral 
care methods. For Veillonella and Actinomyces, no 
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groups (Table 2).
Occurrence of microorganism against 
respective antimicrobial agents
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higher percentages of dominant microorganisms 
found in group I than those of group II. To investigate 
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Antibiotics Percentage of drug-resistance in 25 cases
C. glabrata C. krusei
Sample # % Sample # %
Itraconazole 25 100 16 60
Miconazole 5 20 11 44
Fluconazole 5 20 8 32
	
 2 8 7 28
Amphotericin B S - S -
Voriconazole S - S -
Micafungin S - S -
Table 3- Prevalence of Candida species against respective antibiotics
S=Susceptible
Bacterial Species 
=
Group I (n=43) Group II (n=35)
No. of positive 
samples
Percentage (%) No. of positive 
samples
Percentage (%)
Streptococcus 24 55.8 10 28.6*
Staphylococcus 32 74.4 14 40*
Pseudomonas 30 69.8 12 34.3*
Veillonella 12 27.9 8 22.8
Neisseria 20 46.5 9 25.7*
Actinomyces 15 34.9 8 22.8
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the reason behind this dominant character, we 
studied the occurrence of microorganisms against 
the antimicrobial agents by categorizing the 
remaining group I participants (50 cases) with 
their history of treatment with commonly practiced 
antimicrobial agents (Table 1) after the treatment 
for oral cancer. These 50 participants were divided 
as 25 cases for the study against antifungal agents 
and remaining 25 against antibacterial agents.
The participants after the treatment of 
oral cancer were taking commonly practiced 
antifungal agents such as Itraconazole, Miconazole, 
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Voriconazole and Micafungin. The isolates were 
tested for the presence of Candida species. Except 
for the C. glabrata and C. krusei species, all other 
species were susceptible to the antifungal agents. 
Interestingly, Itraconazole had 100% resistance by 
C. glabrata and 60% resistance by C. krusei species. 
The C. glabrata showed resistance to Miconazole 
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However, C. krusei showed 44%, 32% and 28% 
of resistance respectively. The other drugs were 
susceptible to all Candida species (Table 3).
The antibacterial agents were tested for 
the drug-resistant activity of staphylococci 
subspecies, particularly on methicillin-resistant 
Staphylococcus aureus (MRSA), S. epidermidis 
and S. haemolyticus. The tested agents are 
commonly practiced antibiotics such as Oxacillin, 
Arbekacin, Vancomycin, Teicoplanin, Linezolid, 
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Surprisingly, MRSA showed drug-resistance to 
almost all antibiotics with variation in percentage 
of resistance. The MRSA showed the highest 
percentage of resistance to Oxacillin (96%) 
and Arbekacin. However, the lowest percentage 
(4%) of resistance was shown in relation to 
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species, S. epidermidis and S. haemolyticus, 
showed resistance to Oxacillin with 60 and 40%, 
respectively. However, S. haemolyticus showed the 
lowest percentage (4%) of resistance in relation 
to Arbekacin. All other antibiotics were found 
susceptible to these species.
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Antibiotics Percentage of drug-resistance in 25 cases
MRSA S. epidermidis S. haemolyticus
Sample # % Sample # % Sample # %
Oxacillin 24 96 15 60 10 40
Arbekacin 12 48 S - 1 4
Vancomycin 8 32 S - S -
Teicoplanin 5 20 S - S -
Linezolid 3 12 S - S -
Imipenem/
cilastatin
3 12 S - S -
Amikacin 1 4 S - S -
 1 4 S - S -
Table 4- Prevalence of bacterial species against respective antibiotics
S=Susceptible
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DISCUSSION
In this study, a prevalence of drug-resistant 
microorganisms in the oral cavity after treatment 
of oral cancer was performed in aged Chinese. The 
study was carried out in Ninth People’s Hospital, 
School of Medicine, Shanghai Jiao Tong University, 
Shanghai. The participants were the patients 
from this hospital who had undergone oral cancer 
treatment and others without any history of cancer 
but that could be patients who had undergone 
treatment for other oral diseases. This study was 
aimed to investigate the reason behind the frequent 
cause of oral infection after the treatment of oral 
cancer in elderly individuals.
Several lines of evidence support our views 
that there is a possibility of drug-resistant 
microbes present in immunocompromised patients, 
particularly after the treatment of oral cancer. 
In general, infections are commonly found in 
oral cancer patients after surgical excision of the 
tumor17–20. This might be due to wound exposure 
during and after the operation, even if sutured, 
when microorganisms may infect oral regions, 
oropharynx, nasal cavity, and paranasal sinuses 
areas. Patients after oral cavity surgery often 
appear to have complications after bacterial 
infections, as well. Colonization of pathogenic 
bacteria in oral cavity is thought to increase 
the risk of infections such as pneumonia and 
bacteraemia4,7. It is therefore of high importance 
the prevention from or cure for the infections. 
During the development of tumor, the tumor cells or 
soluble products produced by tumor cells inactivate 
lymphocytes and provoke immunosuppression in 
the body9,12.
The high percentages of microbial species 
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Candida, Staphylococcus, Streptococcus and 
Pseudomonas species (Figure 2). The highest 
numbers of these species were found in patients 
after the treatment of oral cancer in comparison 
with the non-cancer patients (Tables 1 and 2). 
Similar results were obtained in a phase 1 clinical 
trial with the application of an antibacterial dressing 
spray in the prevention of post-operative infection 
in oral cancer patients25. Antimicrobial drugs 
have been very helpful to prevent infections after 
surgery. People, however, sometimes misuse them 
and have antimicrobial drugs abuse. The abuse of 
antimicrobial drugs brings severe adverse effects 
to people, for example, allergy, toxic reaction, and 
opportunistic infections18. As a result, a new and 
ideal preventive method is needed for people who 
have surgery to reduce the chances of bacterial 
infections.
In this study, after revealing the high percentage 
of microorganisms found particularly in post-
treatment of oral cancer, we started to focus 
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microbes. The antimicrobial agents (Figure 1), 
which are common in clinical practice, were taken 
for this study. The isolates were tested for the 
presence of Candida species and subspecies of 
staphylococci, particularly on MRSA, S. epidermidis 
and S. haemolyticus. Except for the C. glabrata 
and C. krusei species, all other Candida species 
were susceptible to the antifungal agents (Table 
3). The MRSA showed the highest percentage of 
resistance to Oxacillin (96%) and Arbekacin. The 
other species, S. epidermidis and S. haemolyticus, 
showed resistance to Oxacillin with 60 and 40%, 
respectively. All other antibiotics were found 
susceptible to these species (Table 4). According 
to a study performed in the United Kingdom, 13 
(41.9%) of 31 S. aureus isolates from the oral 
mucosa and pockets of patients with gingivitis/
2014;22(4):261-7
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periodontitis were mecA-positive (antimicrobial 
resistance)6. Another study, in the United States, 
reported that the prevalence of MRSA organisms 
in the nasal and oral cavities of nursing home 
residents was 20–35%8. Furthermore, a Japanese 
group investigated MRSA colonization in neonatal 
intensive care units and found that 207 (49.9%) 
of 415 newborns had MRSA organisms22. When 
compared with these results, the drug-resistance 
(96%) of MRSA against oxacillin was extremely 
high, possibly due in part to the tendency to 
prescribe long-term, high-dose antibiotic treatment 
in Japan21.
CONCLUSION
Our study revealed a group of opportunistic-
microorganisms such as C. glabrata, C. krusei and 
subspecies of staphylococci, particularly Methicillin-
resistant S. aureus (MRSA), S. epidermidis and 
S. haemolyticus. Nevertheless, anti-tumor drugs 
used in tumor treatment will also lead to immune 
and bone marrow suppression. Therefore, post-
treatment infections occurred13,14. Continuous 
monitoring and a basic infection control strategy, 
including standard precautions, are important 
for older individuals, especially those receiving 
follow-up care for oral cancer. There is always a 
risk that they may become immunocompromised 
hosts easily susceptible to oral infections. Clinicians 
must also pay careful attention to opportunistic-
microorganisms during the treatment of oral cancer, 
and to realize the fact of immune compromise in 
elderly patients.
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